Posted inIndustrial News
Merck Invests $1 Billion in New U.S. Biologics Plant Amid Tariff Preparations
Merck announces $1 billion investment in Delaware biologics plant to boost domestic production of Keytruda cancer drug and prepare for potential pharmaceutical tariffs. Merck Commits $1 Billion to New U.S. Biologics Facility as Tariff…
